This article explains how COVID-19 accelerated the shift toward digital KOL engagement in the pharmaceutical industry. As in-person events declined, virtual platforms became essential for maintaining strong relationships with key opinion leaders. The piece highlights the importance of clear objectives, selecting the right KOLs, using intuitive virtual tools, and offering meaningful collaboration opportunities to build effective and lasting digital engagement strategies.